Technology
Health
Biotechnology
Ligand Pharmaceuticals
$113.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$113.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.14 (0.12%) As of 11:34 AM EDT today
+$0.14 (0.12%) Today
Why Robinhood?
You can buy or sell LGND and other stocks, options, ETFs, and crypto commission-free!
About LGND
Ligand Pharmaceuticals Incorporated Common Stock, also called Ligand Pharmaceuticals, is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. Read More The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
Employees
116
Headquarters
San Diego, California
Founded
1987
Market Cap
2.23B
Price-Earnings Ratio
3.24
Dividend Yield
0.00
Average Volume
284.61K
High Today
$115.48
Low Today
$113.50
Open Price
$114.23
Volume
122.65K
52 Week High
$278.62
52 Week Low
$98.56
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
US
North America
LGND News
Price Paid on Robinhood
18% Lower
Right Now
52 Week Low
$98.56
Average Price Paid
$138.54
52 Week High
$278.62
Analyst Ratings
86%
of 7 ratings
Buy
86%
Hold
14%
Sell
0%
LGND Earnings
$1.02
$1.54
$2.07
$2.59
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 30, Pre-Market